Hyperprolactinaemia in primary Sjogren's syndrome [1]
Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been d...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 1994
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/28453
- Acceso en línea:
- http://dx.doi.org/10.1136/ard.53.6.425-a
https://repository.urosario.edu.co/handle/10336/28453
- Palabra clave:
- Hyperprolactinaemia
Primary Sjogren's syndrome
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_0310bcfa84886d990d59aaa651eb1042 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/28453 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
3087f619-dc20-45cb-bea9-a311c04d367019474778600f5b7493a-694e-4bad-918b-6c7454c06f7db8df2593-0af2-42eb-81ec-65f6561e02f86e1eca80-8f45-4be2-a02c-b9dd9c23563c9734735a-713f-4d76-b8d4-0a5b87d6e8652020-08-28T15:48:14Z2020-08-28T15:48:14Z1994-01-01Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been described suggesting that PRL may play a role in the pathogenesis of some autoimmune diseases.94 In addition, PRL seems to be an autocrine factor required for viability and proliferation of B lymphoma cells.5 Furthermore, it was recently proposed that hyperprolactinaemia observed in oestrogentreated mice may predispose to development of lymphoma in these animals.6 Primary Sj6gren's syndrome (P-SS) is a chronic autoimmune disease characterised by exocrine glandular insufficiency secondary to lymphocytic and plasma cell infiltration. The spectrum of the disease extends from an organ specific autoimmune disease to a systemic involvement.7 Characteristically, patients with Sjogren's syndrome (SS) have an increased risk of developing lymphoma.'application/pdfhttp://dx.doi.org/10.1136/ard.53.6.425-aISSN: 0003-4967EISSN: 1468-2060https://repository.urosario.edu.co/handle/10336/28453engBMJ Publishing Group428No. 53425Annals of the Rheumatic DiseasesAnnals of the Rheumatic Diseases, ISSN: 0003-4967; EISSN: 1468-2060, No.53 (June, 1994); pp. 425-428https://ard.bmj.com/content/53/6/425.1Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Annals of the Rheumatic Diseasesinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHyperprolactinaemiaPrimary Sjogren's syndromeHyperprolactinaemia in primary Sjogren's syndrome [1]Hiperprolactinemia en el síndrome de Sjogren primario [1]articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Gutiérrez, M.A.Anaya, Juan-ManuelScopelitis E.Citera, G.Silveira, L. H.Espinoza, L.10336/28453oai:repository.urosario.edu.co:10336/284532021-08-10 21:44:48.495https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
dc.title.TranslatedTitle.spa.fl_str_mv |
Hiperprolactinemia en el síndrome de Sjogren primario [1] |
title |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
spellingShingle |
Hyperprolactinaemia in primary Sjogren's syndrome [1] Hyperprolactinaemia Primary Sjogren's syndrome |
title_short |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
title_full |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
title_fullStr |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
title_full_unstemmed |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
title_sort |
Hyperprolactinaemia in primary Sjogren's syndrome [1] |
dc.subject.keyword.spa.fl_str_mv |
Hyperprolactinaemia Primary Sjogren's syndrome |
topic |
Hyperprolactinaemia Primary Sjogren's syndrome |
description |
Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been described suggesting that PRL may play a role in the pathogenesis of some autoimmune diseases.94 In addition, PRL seems to be an autocrine factor required for viability and proliferation of B lymphoma cells.5 Furthermore, it was recently proposed that hyperprolactinaemia observed in oestrogentreated mice may predispose to development of lymphoma in these animals.6 Primary Sj6gren's syndrome (P-SS) is a chronic autoimmune disease characterised by exocrine glandular insufficiency secondary to lymphocytic and plasma cell infiltration. The spectrum of the disease extends from an organ specific autoimmune disease to a systemic involvement.7 Characteristically, patients with Sjogren's syndrome (SS) have an increased risk of developing lymphoma.' |
publishDate |
1994 |
dc.date.created.spa.fl_str_mv |
1994-01-01 |
dc.date.accessioned.none.fl_str_mv |
2020-08-28T15:48:14Z |
dc.date.available.none.fl_str_mv |
2020-08-28T15:48:14Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
http://dx.doi.org/10.1136/ard.53.6.425-a |
dc.identifier.issn.none.fl_str_mv |
ISSN: 0003-4967 EISSN: 1468-2060 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/28453 |
url |
http://dx.doi.org/10.1136/ard.53.6.425-a https://repository.urosario.edu.co/handle/10336/28453 |
identifier_str_mv |
ISSN: 0003-4967 EISSN: 1468-2060 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
428 |
dc.relation.citationIssue.none.fl_str_mv |
No. 53 |
dc.relation.citationStartPage.none.fl_str_mv |
425 |
dc.relation.citationTitle.none.fl_str_mv |
Annals of the Rheumatic Diseases |
dc.relation.ispartof.spa.fl_str_mv |
Annals of the Rheumatic Diseases, ISSN: 0003-4967; EISSN: 1468-2060, No.53 (June, 1994); pp. 425-428 |
dc.relation.uri.spa.fl_str_mv |
https://ard.bmj.com/content/53/6/425.1 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
BMJ Publishing Group |
dc.source.spa.fl_str_mv |
Annals of the Rheumatic Diseases |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167713312931840 |